Menopause Review
facebook
eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Online First About the journal Editorial board Editorial office Publisher Abstracting and indexing Subscription Contact Ethical standards and procedures Special Issues Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2020
vol. 19
 
Share:
Send email
Share:
abstract:
Original paper

Elevated and diagnostic androgens of polycystic ovary syndrome

Ibrahim A. Abdelazim
1, 2
,
Ahmed Alanwar
1
,
Mohannad AbuFaza
2
,
Osama O. Amer
3
,
Yerbol Bekmukhambetov
4
,
Gulmira Zhurabekova
5
,
Svetlana Shikanova
6
,
Bakyt Karimova
6

  1. Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
  2. Department of Obstetrics and Gynecology, Ahmadi Hospital, Kuwait Oil Company (KOC), Ahmadi, Kuwait
  3. Department of Oncology, Ghamra Military Hospital, Cairo, Egypt
  4. Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  5. Department of Normal and Topographic Anatomy, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  6. Department of Obstetrics and Gynecology No. 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Menopause Rev 2020; 19(1): 1-5
DOI: https://doi.org/10.5114/pm.2020.95293
Online publish date: 2020/04/27
View full text Get citation
 
PlumX metrics:
Introduction
A genetic variation at the level of aromatase enzyme and/or androgen receptors was suggested in polycystic ovary syndrome (PCOS).

Aim of the study
To determine the androgens elevated and diagnostic for PCOS.

Material and methods
A total of 120 PCOS women were compared to non-PCOS controls in this study. The studied women were evaluated thoroughly, including: day 2-3 hormonal profile and any hormonal change confirmed by two laboratory results eight weeks apart. Collected data were analysed to determine the androgens elevated and diagnostic for PCOS.

Results
The luteinising hormone (LH) and LH/follicle stimulating hormone (FSH) ratio were significantly high in the studied PCOS group compared to controls (p = 0.02 and 0.01, respectively). In addition, total and free testosterone and androstenedione were significantly high in the studied PCOS group compared to controls (p = 0.001, 0.003, and 0.02, respectively). The studied PCOS group had higher relative risk (RR) and odds ratio (OR) of elevated total testosterone (2.4 and 5.7, respectively), elevated free testosterone (2.9 and 4.9, respectively), and elevated androstenedione (3.0 and 4.8, respectively), compared to controls.

Conclusions
Testosterone (both total and free testosterone) and androstenedione were the main elevated androgens and were diagnostic for excess ovarian androgens in the studied PCOS women, whereas dehydroepiandrosterone (DHEA) was not elevated and/or diagnostic for excess ovarian androgens in the studied PCOS women.

keywords:

elevated, diagnostic, androgens, PCOS

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.